Header Logo

Connection

GEORGE VAN BUREN to Cetuximab

Back to Details
This is a "connection" page, showing publications GEORGE VAN BUREN has written about Cetuximab.
GEORGE VAN BUREN
Connection Strength
0.041
Cetuximab
  1. Mesothelin and TGF-a predict pancreatic cancer cell sensitivity to EGFR inhibitors and effective combination treatment with trametinib. PLoS One. 2019; 14(3):e0213294.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.